|
Synthon Chiragenics Corp.. (Markets: Life sciences).(research agreement with Brigham and Women's Hospital)(Brief Article)
From:
Chemical Market Reporter
| Date:
November 19, 2001
| COPYRIGHT 2001 Schnell Publishing Company, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.Copyright information
|
SYNTHON Chiragenics Corp. has signed an agreement with Harvard University-affi...
Related newspaper, magazine, and journal articles from HighBeam Research
|
|
Synthon Chiragenics Corp.. (Markets: Life sciences).(research agreement with Brigham and Women's Hospital)(Brief Article)
Chemical Market Reporter
; SYNTHON Chiragenics Corp. has signed an agreement with Harvard University-affiliated The Brigham and Women's Hospital, to research antibacterial candidates.
|
|
|
Avecia acquires carbohydrates-based chiral technologies from Synthon Chiragenics. (News).(Brief Article)
Chemical Market Reporter
; THIS WEEK, at the Informex trade show in New Orleans, La., Avecia will announce its acquisition of the pharmaceutical fine chemicals business of Synthon Chiragenics Corp., a Monmouth Junction, N.J., developer of carbohydrates-based chiral technologies. Terms of the deal have not been disclosed.
|
|
|
Suven acquires Synthon Chiragenics. (Markets Plus: Custom Manufacturing).(Suven Pharmaceuticals Ltd. buys assets of Monmouth, N.J.-based Synthon Chiragenics)
Chemical Market Reporter
; SUVEN Pharmaceuticals Ltd., a Hyderabad, India-based contract research and manufacturing company, has acquired the assets of Monmouth, N.J.-based Synthon Chiragenics, a developer of carbohydrate-based technologies. Terms were not disclosed. The pharmaceutical fine chemicals business, including
|
|
Cambrex Links with Synthon.
Chemical Week
; Cambrex has signed a four-year collaboration agreement with Synthon Chiragenics (Monmouth Junction, NJ) to develop and supply chiral compounds for pharmaceuticals. Cambrex says it will invest $3 million in Synthon in exchange for an equity ownership position and warrants for additional ownership.
|
|
|
Cambrex Signs Chiral Collaborative Deal With Synthon Chiragenics.(Brief Article)
Chemical Market Reporter
; CAMBREX CORPORATION will invest $3 million in Synthon Chiragenics Corporation as part of a four-year collaborative agreement to develop, manufacture and supply advanced chiral compounds for use in therapeutic drugs. In exchange, Cambrex will gain an equity ownership position in Synthon and warrants
|
|
|
Avecia buys Synthon Chiragenics' chirals business. (M&A).(Avecia acquires Synthon Chiragenics' pharmaceutical fine chemicals operations)
Chemical Week
; Avecia says it has acquired the pharmaceutical fine chemicals business of Synthon Chiragenics (Monmouth Junction, NJ), including its proprietary chiral technologies. The acquisition involves Synthon's pharma fine chemicals activities, which consists of a lactones and derivatives business. Terms
|
|
Technology-Based Firm Wins Private Company Award in New Jersey.
Knight Ridder/Tribune Business News
; By Cheryl Sarfaty, Home News Tribune, East Brunswick, N.J. Knight Ridder/Tribune Business News Dec. 7--MONMOUTH JUNCTION, N.J.--Synthon Chiragenics ... people in the last year. To see more of the Home News Tribune, or to subscribe to the newspaper, go ...
|
|
|
Synthon Sets Its Sights on Drugs For Cancer and Autoimmune Diseases.(Brief Article)
Chemical Market Reporter
; SYNTHON CHIRAGENICS Corp. has broadened the reach of its carbohydrate-based chiral technology platform into a hot area of drug discovery, carbohydrate-based therapeutics. Using its technology to prepare molecules that regulate complex carbohydrate and nucleic acid synthesis, Synthon is developing a
|
|
Technology-transfer activity.(Michigan State University)(Brief Article)
Crain's Detroit Business
; Some companies that have recently licensed technology from Michigan universities: * Arbor Networks Inc., Ann Arbor Provides a computer network security service based on technology developed at the University of Michigan College of Engineering. * Artemis Express, Ann Arbor Founded by a group of
|
|
|
A time of change for custom manufacturing/fine chemicals. (Focus 2003: Fine Chemicals Leaders: CEOs and Companies).
Chemical Market Reporter
; Reorganizations, restructuring and modest investments top the agenda of some of the leading custom manufacturers/fine chemical producers. As custom manufacturers/fine chemical producers wait for improvement in drug output, several companies will wait to see whether recently shifted organizations,
|